DHC Pediatric Webinar - Treating ADHD in Young Children: Updates and Innovations

Tuesday, November 12, 2024, 8:00 AM - Friday, November 12, 2027, 9:00 AM

AMA PRA Category 1 Credits™ (1.00 hours), ANCC Nursing Contact Hours (1.00 hours), CME-Designated Participation Credit (1.00 hours)

This Pediatric Lecture Series will discuss important pediatric topics that may lead to the improvement of child health from an individual, health care system and/or societal level.

Presenter

James T. Craig, MA, PhD
Psychiatry
Dartmouth Health, Lebanon, NH

As a child psychologist, Dr. Craig’s goal is to provide children and families with evidence-based treatments in the context of a strong therapeutic relationship. His work is aimed at providing services to a diverse group of patients and help them address common behavior problems that occur in children and adolescents. In his therapeutic work, he strives to treat each child or teen as an individual and match their specific challenges and strengths with a treatment approach capable of improving their quality of life and supporting a successful future. He provides behavioral therapy and cognitive-behavioral therapy to children and adolescents ages 2-19. His clinical interests are foremost in the treatment of aggressive, defiant, and disruptive behaviors. Many of his clients present with challenges related to diagnoses of ADHD, Oppositional Defiant Disorder, or Conduct Disorder. He has a deep interest in the treatment of sleep disorders and elimination disorders (e.g., bedwetting, difficulties toilet training). Dr. Craig also welcomes referrals for children and teens seeking help for anxiety, OCD, depression, somatic distress, and family conflict.

In addition to his clinical work, Dr. Craig also conducts research and provides training to developing therapists. His research interests are in the areas of bullying prevention and the development of treatments for children with aggressive and defiant behaviors that do not have access to traditional mental healthcare. He currently serves as the Lead Supervisor of Child Psychotherapy Training for both the Psychiatry and Psychology trainees within the Department of Psychiatry. JT enjoys sharing his knowledge and learning from our remarkable trainees.

1. Discuss the AAP Guidelines for screening and diagnosis of ADHD in early childhood.
2. Describe the treatment options for young children with ADHD, including the evidence that support these interventions.
3. Identify innovations in the treatment of ADHD currently being tested and developed at Dartmouth Health.

In support of improving patient care, Dartmouth Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

American Medical Association (AMA)
Dartmouth Health designates this Enduring Material for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

American Nurses Credentialing Center (ANCC)
Dartmouth Health designates this Enduring Material for a maximum of 1.00 ANCC contact hours.

All other learners may claim CME-designated participation credit. Consult your professional licensing board regarding the applicability and acceptance of CME-designated participation credit for programs certified for credit by organizations accredited by Joint Accreditation for Interprofessional Education.

Registration/Requirements for Successful Completion
You may claim credit for successful completion of this online course. In order to claim credit, you must follow these steps:

1. Click the Register tab above. If you are not logged into your account, you will need to log in. Use the Forgot Your Password? button if you need to reset your password.
2. Register for the activity.
3. Click the Content/Tests tab and then View Content to view the recording. View the entire presentation.
4. Complete the Post-Test (attestation - return to the Content/Tests tab to find it).
5. Click the Complete Evaluation button, or click My Account in the menu bar; then click Evaluations.
6. Complete and Submit the Evaluation.

Bibliographic Material

• Sibley MH, Bruton AM, Zhao X, Johnstone JM, Mitchell J, Hatsu I, Arnold LE, Basu HH, Levy L, Vyas P, Macphee F, Gonzalez ES, Kelley M, Jusko ML, Bolden CR, Zulauf-McCurdy C, Manzano M, Torres G. Non-pharmacological interventions for attention-deficit hyperactivity disorder in children and adolescents. Lancet Child Adolesc Health. 2023 Jun;7(6):415-428. https://doi.org/10.1016/S2352-4642(22)00381-9. Epub 2023 Mar 9. PMID: 36907194; PMCID: PMC10370370.
  
  
• Ollendick, T. H., King, N. J., & Chorpita, B. F. (2006). In P. K. Kendall (Ed) Child and Adolescent Therapy: Cognitive Behavioral Procedures.  New York, NY: Guilford Press
  
  
• Patterson, G. R., (2016).  Coercion Theory: The Study of Change.  In J.J. Snyder & T. J. Dishion (Eds.), The Oxford Handbook of Coercive Relationship Dynamics, New York: Oxford Press
  
  
• Phillips, S. T., Druskin, L. R., Mychailyszyn, M. P., Victory, E., Aman, E., & McNeil, C. B. (2024). The Efficacy of Parent–Child Interaction Therapy (PCIT) for Youth with Attention-Deficit/Hyperactivity Disorder (ADHD): A Meta-Analysis. Child Psychiatry & Human Development, 1-10. https://doi.org/10.1007/s10578-024-01678-2
  
  
• Riddle, M. A., Yershova, K., Lazzaretto, D., Paykina, N., Yenokyan, G., Greenhill, L., Abikoff, H., Vitiello, B., Wigal, T., McCracken, J. T., Kollins, S. H., Murray, D. W., Wigal, S., Kastelic, E., McGough, J. J., dosReis, S., Bauzo?Rosario, A., Stehli, A., & Posner, K. (2013). The preschool attention?deficit/hyperactivity disorder treatment study (PATS) 6?year follow?up. Journal of the American Academy of Child & Adolescent Psychiatry, 52(3), 264–278.e2. https://doi.org/10.1016/j. jaac.2012.12.007
  
  
• Rushton, J., Bruckman, D., & Kelleher, K. (2002). Primary care referral of children with psychosocial problems. Archives of Pediatrics and Adolescent Medicine, 156, 592–598. http://dx.doi.org/10.1001/archpedi.156.6.592
  
  
• Snyder, J. J. & Dishion, T. J. (2016). The Oxford Handbook of Coercive Relationship Dynamics, New York: Oxford Press
  U.S. Department of Health and Human Services: Office of Inspector General. Many Medicaid enrolled children who were treated for ADHD did not receive recommended follow-up care; 2019. 
  
  
• Sugaya, L.S., Farhat, L.C., Calfano, P., & Polanczyk, G.V. Efficacy of stimulants for preschool attention deficit/hyperactivity disorder: A systematic review and meta-analysis. Journal of Child Psychiatry and Psychology, 3, 1-10. https://doi.org/10.1002/jcv2.1214
  
  
• Thomas, R., Sanders, S., Doust, J., Beller, E., & Glasziou, P. (2015). Prevalence of attention-deficit/hyperactivity disorder: a systematic review and meta-analysis. Pediatrics, 135(4), e994-e1001. https://doi.org/10.1542/peds.2014-3482 
  
  
• Weisenmuller, C., & Hilton, D. (2021). Barriers to access, implementation, and utilization of parenting interventions: Considerations for research and clinical applications. American Psychologist, 76(1), 104. https://doi.org/10.1037/amp0000613 
  
  
• Wolraich ML, Hagan JF, Allan C, Chan E, Davison D, Earls M, et al. Subcommittee on Children and Adolescents with Attention-Deficit/Hyperactivity Disorder. Clinical practice guidelines for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics. 2019;144(4):1-25. PMCID: PMC7067282
  
  

Provider Contact Information
Provider contact information for questions regarding accreditation of the activity:

Center for Learning and Professional Development
ACE Office
Dartmouth Health
[email protected]

Mitigation of Relevant Financial Relationships

Dartmouth Health adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education.  Any individuals in a position to control the content of a CE activity, including planners, faculty, authors, or others are required to disclose all financial relationships with ineligible companies^.  All relevant financial relationships have been mitigated prior to the commencement of the activity.

^Ineligible Company is any entity whose primary business purpose is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.